.jpg)
.png)
All
The National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia Friday, May 2 • 6:45 – 7:45 a.m. As you know, the American College of Cardiology and the American Heart Association last fall released the 2013 ACC/AHA Guideline on the Treatment of Blood... more
The outcomes of a Global think tank on the clinical considerations & management of lipoprotein(a): The top questions and answers regarding what clinicians need to know published online in Progress in Cardiovascular Disease. Participating organizations include the Association of Black... more
Introduction Solid organ transplantation (SOT), encompassing kidney, liver, heart and to a lesser extent pancreas and lung, has become routine care for optimal treatment of end-stage disease in many patients.1,2 Refinements in transplantation protocols have helped preserve transplanted organs... more
2015 SATELLITE SYMPOSIA GUIDELINES The National Lipid Association (NLA) has established that independently developed and CME/CE certified satellite symposia held in conjunction with the scientific meetings of the NLA are valuable opportunities to provide continuing education for our members. In... more
Familial defective apolipoprotein B-100 (FDB) is an autosomal dominant disorder of lipid metabolism considered by international guidelines to be a genetically defined cause of familial hypercholesterolemia (FH).1–3 FDB arises from mutations in apolipoprotein B (apoB) affecting the affinity of apoB-... more
NYU Langone’s Center for the Prevention of Cardiovascular Disease offers a one-year, nonaccredited training program in preventive cardiology and metabolic health. The Preventive Cardiology Fellowship provides extensive clinical training in both primary and secondary... more
My fellow members of the National Lipid Association, I am very happy to bring you yet another Northeast and Southeast Chapter-hosted edition of LipidSpin. When the editorial calendar was revamped last year, we fully intended this edition to roll off the presses in time to make the rounds at the... more
“None of us, including me, ever do great things. But we can all do small things, with great love, and together we can do something wonderful.” – Mother Teresa A collaborative leadership has the influence to transform health-systems and healthcare organizations, improving the system today and... more
Introduction Obesity is a complex, chronic medical condition. Although defined by a BMI >30 kg/m2, it is now understood to be much more than a BMI cutoff and modulated by neuroendocrine mechanisms with emerging therapeutic options.1,2 Clinical guidelines recommend medical treatment for obese... more
Cardiovascular disease (CVD) remains the leading cause of death for women in the United States.(1) Unique factors affecting a woman’s health contribute significantly to CVD risk, but historically were not always represented in major guidelines. Some of these factors include hormonal changes, the... more